Table 5.
Placebo |
MGS Supplement |
MGS vs Placebo** |
|||||
---|---|---|---|---|---|---|---|
Baseline |
Follow-up |
Baseline |
Follow-up |
||||
Marker | Mean (SEM) | Mean (SEM) | p Value* | Mean (SEM) | Mean (SEM) | p Value* | p Value |
MDA, μM | 0.50 (0.04) | 0.43 (0.03) | 0.05 | 0.54 (0.03) | 0.44 (0.03) | 0.01 | 0.61 |
8-isoprostane, pg/mL | 152.7 (11.0) | 179.7 (12.0) | 0.002 | 157.0 (11.4) | 161.9 (11.8) | 0.64 | 0.08 |
Total antioxidant capacity, mM† | 0.65 (0.01) | 0.66 (0.01) | 0.86 | 0.65 (0.01) | 0.65 (0.01) | 0.85 | 0.80 |
Least squares means contrast from the mixed linear model.
Test of treatment effect in the mixed linear model.
mM uric acid equivalents.
MGS = muscadine grape seed; MDA = malondialdehyde.